Probiotics for woman’s health focus on urogenital infections and reproductive outcomes


  • Phagun Shah Department of Obstetrics and Gynecology, Zeal Maternity and Nursing Home, Ahmedabad, Gujarat, India
  • Pratap Kumar Department of Obstetrics and Gynecology, KMC Manipal, Manipal University, Karnataka, India
  • Mukesh Gupta Department of Obstetrics and Gynecology, Le’Nest Hospital, Mumbai, Maharashtra, India
  • Mohan Gadam Department of Obstetrics and Gynecology, Eva Medicare, Mumbai, Maharashtra, India
  • Kedar Ganla Department of Obstetrics and Gynecology, Ankoor Fertility Clinic and IUI Center, Mumbai, Maharashtra, India
  • Priti Kumar Department of Obstetrics and Gynecology, Sunflower Medical and Gynae Center, Lucknow, Uttar Pradesh, India
  • Roshi Satija Department of Obstetrics and Gynecology, Dr. Sunderlal Memorial Hospital, New Delhi, India
  • Ashish Kale Department of Obstetrics and Gynecology, Ashakiran Hospital, Pune, Maharashtra, India
  • Sunita Chandra Department of Obstetrics and Gynecology, Morpheus Lucknow Fertility Center, Lucknow, Uttar Pradesh, India



Invitro fertilization, Lactobacilli, Probiotics, Pregnancy, Urogenital infections


Depletion in vaginal Lactobacilli colonization is associated with poor urogenital health and adverse pregnancy outcomes. Probiotic supplements containing lactobacilli, when administered in adequate amounts, increased vaginal and gut colonization of Lactobacilli, reduced the incidence of bacterial vaginosis and other urogenital infections. Probiotic Lactobacilli reduced preterm births and improved fertility rates in women following in vitro fertilization. Probiotics may also improve implantation rate and live-birth rate in women undergoing IVF. The purpose of this review was to critically analyse the available literature for synthesizing evidence on the use of probiotics and its effect on urogenital and reproductive health in women.


Sirota I, Zarek SM, Segars JH. Potential influence of the microbiome on infertility and assisted reproductive technology. Semin Reprod Med. 2014;32(1):35-42.

Amabebe E, Anumba DOC. The vaginal microenvironment: the physiologic role of lactobacilli. Front Med. 2018;5:181.

Tachedjian G, Aldunate M, Bradshaw CS, Cone RA. The role of lactic acid production by probiotic Lactobacilli species in vaginal health. Res Microbiol. 2017;168(9-10):782-92.

Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic mechanisms of action. Ann Nutr Metab. 2012;61:160-74.

Kumar N, Behera B, Sagiri SS, Pal K, Ray SS, Roy S. Bacterial vaginosis: etiology and modalities of treatment- a brief note. J Pharm Bioall Sci. 2011;3:496-503.

Macklaim JM, Clemente JC, Knight R, Gloor GB, Reid G. Changes in vaginal microbiota following antimicrobial and probiotic therapy. Microb Ecol Health Dis. 2015;26:27799.

Senok AC, Verstraelen H, TemmermanM, Botta GA. Probiotics for the treatment of bacterial vaginosis. Cochrane Database Systematic Reviews. 2009;4:Art No.:CD006289.

Machado D, Castro J, Palmeira-de-Oliveira A, Martinez-de-Oliveira J, Cerca N. Bacterial vaginosis biofilms: challenges to current therapies and emerging solutions. Front Microbiol. 2016;6:1528.

Sharma S, Agarwal N, Verma P. Probiotics: the emissaries of health from microbial world. J Appl Pharm Sci. 2012;2(1):138-43.

Slačanac V, Hardi J, Lučan M, Božanić R, Galić S, Koceva-Komlenić D. Prevention of urogenital infections, Mljekarstvo. 2010;60(3):156-65.

Govender M, Choonara YE, Kumar P, du Toit LC, Vuuren S, Pillay V. A review of the advancements in probiotic delivery: conventional vs. non-conventional formulations for intestinal flora supplementation. AAPS Pharm Sci Tech. 2014;15(1):29-43.

Reid G, Charbonneau D, Erb J, Koachanowski B, Beuerman D, Poehner R, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003;35(2):131-4.

Anukam K, Osazuwa E, Ahonkhai I, Ngwo M, Osemene G, Bruce AW, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacilli rhamnosus GR1 and Lactobacilli reuteri RC14: Randomized double-blind placebo-controlled trial. Microbes Infect. 2006;8:1450-4.

Vigneshwari RS, Rambabu, T. Jeyaseelan Senthinath, Revathi P, Uma DA. Role of probiotics in the treatment of bacterial vaginosis. Int J Sci Technol Res. 2014;3(4):1-4.

Heczko B, Tomusiak A, Adamski P, Jakimiuk AJ, Stefański G, Mikołajczyk-Cichońska A, et al. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: A randomised, double-blind, placebo-controlled trial BMC Women's Health. 2015;15:115.

Martinez RC, Franceschini SA, Patta MC, Quintana SM, Gomes BC, De Martinis EC, et al. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacilli rhamnosus GR-1, and Lactobacilli reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can J Microbiol. 2009;55(2):133-8.

Vujic G, Jajac Knez A, Despot Stefanovic V, Kuzmic Vrbanovic V. Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2013;168(1):75-9.

Moreno I, Codoñer FM, Vilella F, Valbuena D, Martinez-Blanch JF, Jimenez-Almazán J, et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol. 2016;215(6):684-703.

Haahr T, Jensen JS, Thomsen L, Duus L, Rygaard K, Humaidan P. Abnormal vaginal microbiota may be associated with poor reproductive outcomes: a prospective study in IVF patients. Human Reprod. 2016;31(4):795-803.

Van Oostrum N, De Sutter P, Meys J, Verstraelen H. Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis. Hum Reprod. 2013;28(7):1809-15.

Homayouni A, Bastani P, Ziyadi S, Mohammad-Alizadeh-Charandabi S, Ghalibaf M. Effects of probiotics on the recurrence of bacterial vaginosis: A review. J Low Genit Tract Dis. 2014;18(1):79-86.

Price MJ, Ades AE, Soldan K. The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis. Southampton (UK): NIHR Journals Library; 2016.

Haggerty CL, Totten PA, Tang G, Astete SG, Ferris MJ. Identification of noel microbes associated with pelvic inflammatory disease and infertility. Sexually Trans Inf. 2016;92(6):441-6.

Haahr T, Zacho J, Bräuner M, Shathmigha K, Skov JJ, Humaidan, P. Reproductive outcome of patients undergoing in vitro fertilisation treatment and diagnosed with bacterial vaginosis or abnormal vaginal microbiota: a systematic PRISMA review and meta-analysis. BJOG. 2019;126(2):200-7.

Brown RG, Marchesi JR, Lee YS, Smith A, Lehne B. Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin. BMC Med. 2018;16:9.

Yang S, Reid G, Challis RG, Kim SO, Gloor GB. Is there a role for probiotics in the prevention of preterm birth? Front Immunol. 2015;6:62.

Reid JN, Bisanz JE, Monachese M, Burton JP, Reid G. The rationale for probiotics improving reproductive health and pregnancy outcome. Am J Reprod Immunol. 2013;69(6):558-66.

Myhre R, Brantsæter AL, Myking S, Gjessing HK, Sengpiel V, Meltzer HM, Haugen M, Jacobsson B. Intake of probiotic food and risk of spontaneous preterm delivery. Am J Clin Nutr. 2011;93(1):151-7.

Nordqvist M, Jacobsson B, Brantsæter AL, Myhre R, Nilsson S, Sengpiel V. Timing of probiotic milk consumption during pregnancy and effects on the incidence of preeclampsia and preterm delivery: a prospective observational cohort study in Norway. BMJ Open. 2018;8(1):e018021.

García-Velasco JA, Menabrito M, Catalán IB. What fertility specialists should know about the vaginal microbiome: a review. Reprod Biomed Online. 2017;35(1):103-12.

Peymani R, DeCherney A. Microbiome, Infection and Inflammation in Infertility. Genital Infect Infert. 2016:99.

Maduka RN, Osaikhuwuomwan JA, Aziken ME. The effect of bacterial colonization of the embryo transfer catheter on Outcome of In vitro Fertilization-Embryo transfer treatment. Afr J Med Health Sci. 2018;17:7-13.

Moore DE, Soules MR, Klein NA, Fujimoto VY, Agnew KJ, Eschenbach DA. Bacteria in the transfer catheter tip influence the live-birth rate after in vitro fertilization. Fertil Steril. 2000;74(6):1118-24.

Hyman RW, Herndon CN, Jiang H, Palm C, Fukushima M, Bernstein D, Vo KC, et al. The dynamics of the vaginal microbiome during infertility therapy with in vitro fertilization-embryo transfer. J Assist Reprod Genet. 2012;29:105-15.

Akopians AL, Pisarska MD, Wang ET. The role of inflammatory pathways in implantation failure: chronic endometritis and hydrosalpinges. Semin Reprod Med. 2015;33(4):298-304.

Khan KN, Fujishita A, Masumoto H, Muto H, Kitajima M, Masuzaki H, et al. Molecular detection of intrauterine microbial colonization in women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2016;199:69-75.

Kamala S, Priya S. Benefits of probiotic treatment in cases of bad obstetric history (BOH) and for prevention of post IVF pregnancy complications. J Obstet Gynecol India. 2009;59(4):336-9.

Kroon SJ, Ravel J, Huston WM. Cervicovaginal microbiota, women's health, and reproductive outcomes. Fertil Steril. 2018;110(3):327-36.

Moreno I, Simon C. Relevance of assessing the uterine microbiota in infertility. Fertil Steril. 2018;110(3):337-43.

Simon C. Introduction: do microbes in the female reproductive function matter? Fertil Steril. 2018;110(3):325-6.






Review Articles